Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention-A Lescol Intervention Prevention Study (LIPS) substudy

Diabetes is a consistent clinical predictor of cardiovascular complications and fluvastatin reduces the increased incidence of long-term adverse complications associated with the presence of diabetes.